Malignant Adenomyoepithelioma of the Breast: An Unexpected Malignancy in a Lynch Syndrome Patient

Abstract

Keywords

Get full access to this article

View all access options for this article.

References

International Agency for Research on Cancer. WHO Classification of Tumours Editorial Board - Breast Tumours. 5e éd. IARC Publications; 2019: 43‐46.

Hayes

. Adenomyoepithelioma of the breast: a review stressing its propensity for malignant transformation. J Clin Pathol. 2011;64:477‐484.

Ginter

McIntire

Kurtis

, et al. Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity. Mod Pathol. 2020;33:1764‐1772.

Geyer

Papanastasiou

, et al. Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas. Nat Commun. 2018;9:1816.

Condorelli

Mosele

Verret

, et al. Genomic alterations in breast cancer: level of evidence for actionability according to ESMO scale for clinical actionability of molecular targets (ESCAT). Ann Oncol. 2019;30:365‐373.

Walsh

Buchanan

Cummings

, et al. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res. 2010;16:2214‐2224.